Alessandra Cesano - Feb 8, 2024 Form 3 Insider Report for Zymeworks Inc. (ZYME)

Role
Director
Signature
/s/ Daniel Dex, Attorney-in-Fact
Stock symbol
ZYME
Transactions as of
Feb 8, 2024
Transactions value $
$0
Form type
3
Date filed
2/9/2024, 06:00 PM
Previous filing
Jan 4, 2024
Next filing
Mar 28, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ZYME No securities are beneficially owned 0 Feb 8, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ZYME No securities are beneficially owned Feb 8, 2024 Not applicable 0 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Not applicable.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney